The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Aggressive Risk Factor Reduction Study for Atrial Fibrillation and Implications for the Outcome of Ablation
Open accessAbstract
Background The long-term outcome of atrial fibrillation (AF) ablation demonstrates attrition. This outcome may be due to failure to attenuate the progressive substrate promoted by cardiovascular risk factors.Objectives The goal of this study was to evaluate the impact of risk factor and weight management on AF ablation outcomes.Methods Of 281 consecutive patients undergoing AF ablation, 149 with a body mass index ≥27 kg/m(2) and ≥1 cardiac risk factor were offered risk factor management (RFM) according to American Heart Association/American College of Cardiology guidelines. After AF ablation, all 61 patients who opted for RFM and 88 control subjects were assessed every 3 to 6 months by clinic review and 7-day Holter monitoring. Changes in the Atrial Fibrillation Severity Scale scores were determined.Results There were no differences in baseline characteristics, number of procedures, or follow-up duration between the groups (p = NS). RFM resulted in greater reductions in weight (p = 0.002) and blood pressure (p = 0.006), and better glycemic control (p = 0.001) and lipid profiles (p = 0.01). At follow-up, AF frequency, duration, symptoms, and symptom severity decreased more in the RFM group compared with the control group (all p < 0.001). Single-procedure drug-unassisted arrhythmia-free survival was greater in RFM patients compared with control subjects (p < 0.001). Multiple-procedure arrhythmia-free survival was markedly better in RFM patients compared with control subjects (p < 0.001), with 16% and 42.4%, respectively, using antiarrhythmic drugs (p = 0.004). On multivariate analysis, type of AF (p < 0.001) and RFM (hazard ratio 4.8 [95% confidence interval: 2.04 to 11.4]; p < 0.001) were independent predictors of arrhythmia-free survival.Conclusions Aggressive RFM improved the long-term success of AF ablation. This study underscores the importance of therapy directed at the primary promoters of the AF substrate to facilitate rhythm control strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moderate or severe OSA (AHI ≥ 15) is reported in 20%–62%.330,704,706,710–715”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [330]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In studies, such as the ARREST-AF cohort study or the ACTIVE-AF trial, regular exercise programs exhibited a reduction in AF-related symptoms, AF incidence, and AF recurrence rates [76,77].”
From Atrial Fibrillation in Elite Athletes: A Comprehensive Review of the Literature (2024) · cites this paper as [76]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Other groups have studied the relationship between subjective (grade) or objective (volume/weight) tonsil evaluation and AHI and reported a trend toward significance328 or a significant association.318,329–334”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [330]
Experimental — accuracy not yet measuredIn the citing paper
“Given the high incidence of AF after CTI ablation for typical AFL”
From European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE) (2017) · cites this paper as [166]
In the citing paper
“Intensive weight-reduction management in addition to management of other cardiovascular risk factors (in the range of 10-15 kg weight loss achieved) led to fewer AF recurrences and symptoms compared with an approach based on general advice in obese patients with AF.”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [203]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2007) · Cited by 6,530
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205
Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S.-A., Crijns, H. J. G., Damiano, R. J., Davies, D. W., DiMarco, J., et al. (2012) · Europace · doi:10.1093/europace/eus027 · Cited by 2,722
Self-citationMiyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Bailey, K. R., Abhayaratna, W. P., Seward, J. B., & Tsang, T. S. M. (2006) · Circulation · doi:10.1161/circulationaha.105.595140 · Cited by 2,564
Self-citationAHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update
Pearson, T. A., Blair, S. N., Daniels, S. R., Eckel, R. H., Fair, J. M., Fortmann, S. P., Franklin, B. A., Goldstein, L. B., Greenland, P., Grundy, S. M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000020190.45892.75 · Cited by 1,837
Calkins, H. G., Kück, K., Cappato, R., Brugada, J., Camm, A. J., Chen, S., Crijns, H. J. G. M., Damiano, R. J., Davies, D. W., Dimarco, J., et al. (2012) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-012-9672-7 · Cited by 1,685
Self-citationCalkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S.-A., Crijns, H. J. G., Damiano, R. J., Davies, D. W., DiMarco, J., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2011.12.016 · Cited by 1,456
Self-citationObesity and the risk of new-onset atrial fibrillation
Wang, T. J. (2004) · JAMA · doi:10.1001/jama.292.20.2471 · Cited by 1,427
Wilber, D. J., Pappone, C., Neuzil, P., De Paola, A., Marchlinski, F., Natale, A., Macle, L., Daoud, E. G., Calkins, H., Hall, B., et al. (2010) · JAMA · doi:10.1001/jama.2009.2029 · Cited by 1,170
Wazni, O. M., Marrouche, N. F., Martin, D. O., Verma, A., Bhargava, M., Saliba, W., Bash, D., Schweikert, R., Brachmann, J., Gunther, J., et al. (2005) · JAMA · doi:10.1001/jama.293.21.2634 · Cited by 1,121
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 949
Pathophysiology of Paroxysmal and Persistent Atrial Fibrillation: Rotors, Foci and Fibrosis
Lau, D. H., Linz, D., Schotten, U., Mahajan, R., Sanders, P., & Kalman, J. M. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2017.05.119 · Cited by 140
“[56, 57] Structured physician-directed risk factor and weight management programs have been shown to reduce AF burden and symptoms as well as improved sinus rhythm maintenance following catheter ablation.[58-60] Further, reverse atrial remodelling”
BackgroundSelf-citationChronic obstructive pulmonary disease and atrial fibrillation: an interdisciplinary perspective
Simons, S. O., Elliott, A. D., Sastry, M., Hendriks, J., Arzt, M. E., Rienstra, M., Kalman, J. M., Heidbüchel, H., Nattel, S., Wesseling, G., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa822 · Cited by 138
Self-citationGenetic Obesity and the Risk of Atrial Fibrillation
Chatterjee, N. A., Giulianini, F., Geelhoed, B., Lunetta, K. L., Misialek, J. R., Niemeijer, M. N., Rienstra, M., Rose, L. M., Smith, A. V., Arking, D. E., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.024921 · Cited by 136
Obesity and Atrial Fibrillation: Epidemiology, Pathophysiology and Novel Therapeutic Opportunities
Vyas, V. S., & Lambiase, P. D. (2019) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2018.76.2 · Cited by 137
Anter, E., Di Biase, L., Contreras-Valdes, F. M., Gianni, C., Mohanty, S., Tschabrunn, C. M., Viles-Gonzalez, J. F., Leshem, E., Buxton, A. E., Kulbak, G., et al. (2017) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.117.005407 · Cited by 127
Görenek, B., Pelliccia, A., Benjamin, E. J., Boriani, G., Crijns, H. J. G. M., Fogel, R. I., Gelder, I. C. V., Halle, M., Kudaiberdieva, G., Lane, D. A., et al. (2016) · EP Europace · doi:10.1093/europace/euw242 · Cited by 134
Self-citationTreatment of Patients With Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction
Verma, A., Kalman, J. M., & Callans, D. J. (2017) · Circulation · doi:10.1161/circulationaha.116.026054 · Cited by 124
Self-citationCardiac adipose tissue and atrial fibrillation: the perils of adiposity
Hatem, S. N., Redheuil, A. B., & Gandjbakhch, E. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw001 · Cited by 125
Implications of Inflammation and Fibrosis in Atrial Fibrillation Pathophysiology
Harada, M., & Nattel, S. (2021) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2020.11.002 · Cited by 126
Chyou, J. Y., Barkoudah, E., Dukes, J. W., Goldstein, L. B., Joglar, J. A., Lee, A. M., Lubitz, S. A., Marill, K. A., Sneed, K., Streur, M. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001133 · Cited by 127
Treatment of Atrial Fibrillation
Prystowsky, E. N., Padanilam, B. J., & Fogel, R. I. (2015) · JAMA · doi:10.1001/jama.2015.7505 · Cited by 117
Xiong, Z., Liu, T., Tse, G., Gong, M., Gladding, P. A., Smaill, B. H., Stiles, M. K., Gillis, A. M., & Zhao, J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00835 · Cited by 118
Nurse-led vs. usual-care for atrial fibrillation
Wijtvliet, P., Tieleman, R. G., Gelder, I. C. V., Pluymaekers, N. A. H. A., Rienstra, M., Folkeringa, R., Bronzwaer, P. N. A., Elvan, A., Elders, J., Tukkie, R., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz666 · Cited by 118
Mahajan, R., Stokes, M. B., Elliott, A. D., Munawar, D. A., Khokhar, K. B., Thiyagarajah, A., Hendriks, J., Linz, D., Gallagher, C., Kaye, D. M., et al. (2019) · Heart · doi:10.1136/heartjnl-2019-314770 · Cited by 120
Self-citationArnar, D. O., Mairesse, G. H., Boriani, G., Calkins, H. G., Chin, A., Coats, A. J. S., Deharo, J., Svendsen, J. H., Heidbüchel, H., Isa, R., et al. (2019) · EP Europace · doi:10.1093/europace/euz046 · Cited by 127
Self-citationIs Atrial Fibrillation a Preventable Disease?
Du, X., Dong, J., & Ma, C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.02.020 · Cited by 117
Linz, D., Andrade, J. G., Arbelo, E., Boriani, G., BREITHARDT, G. E., Camm, A. J., Caso, V., Nielsen, J. C., Melis, M. D., Potter, T. J. R. D., et al. (2024) · EP Europace · doi:10.1093/europace/euae070 · Cited by 124
Self-citationAn Exercise and Physical Activity Program in Patients With Atrial Fibrillation
Elliott, A. D., Verdicchio, C. V., Mahajan, R., Middeldorp, M. E., Gallagher, C., Mishima, R. S., Hendriks, J. M. L., Pathak, R. K., Thomas, G., Lau, D. H., et al. (2023) · JACC: Clinical Electrophysiology · doi:10.1016/j.jacep.2022.12.002 · Cited by 116
Self-citationGoudis, C. A., & Ketikoglou, D. G. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.12.120 · Cited by 116
Atrial fibrillation and arterial hypertension
Kallistratos, M. S., Poulimenos, L. E., & Manolis, A. J. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.10.007 · Cited by 114
Lifestyle modifications for treatment of atrial fibrillation
Middeldorp, M. E., Ariyaratnam, J., Lau, D. H., & Sanders, P. (2019) · Heart · doi:10.1136/heartjnl-2019-315327 · Cited by 114
Self-citationImpact of obesity on cardiac metabolism, fibrosis, and function
Mahajan, R., Lau, D. H., & Sanders, P. (2014) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.09.005 · Cited by 109
Self-citationWearables in cardiology: Here to stay
Dagher, L., Shi, H., Zhao, Y., & Marrouche, N. F. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.02.023 · Cited by 107
The Implications of Obesity for Cardiac Arrhythmia Mechanisms and Management
Pathak, R. K., Mahajan, R., Lau, D. H., & Sanders, P. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.10.027 · Cited by 105
Self-citationDonnellan, E., Aagaard, P., Kanj, M. H., Jaber, W. A., Elshazly, M. B., Hoosien, M., Baranowski, B. J., Hussein, A. A., Saliba, W. I., & Wazni, O. M. (2019) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2019.05.018 · Cited by 105
Görenek, B., Pelliccia, A., Benjamin, E. J., Boriani, G., Crijns, H. J. G. M., Fogel, R. I., Gelder, I. C. V., Halle, M., Kudaiberdieva, G., Lane, D. A., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316676037 · Cited by 104
Self-citationChen, L. Y., Leening, M. J. G., Norby, F. L., Roetker, N. S., Albert Hofman, D., Franco, O. H., Pan, W., Polak, J. F., Witteman, J. C. M., Kronmal, R. A., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002907 · Cited by 103
“In a follow-up trial, compared with patients who did not undergo atherosclerosis risk factor management, those who opted for risk factor management had greater reduction in AF frequency, duration, and symptom severity after AF ablation.(55) Furthermore, recent data from randomized, controlled trials have shown that co…”
BackgroundDoes remote monitoring change OSA management and CPAP adherence?
Pépin, J., Tamisier, R., Hwang, D., Mereddy, S., & Parthasarathy, S. (2017) · Respirology · doi:10.1111/resp.13183 · Cited by 102
Parkash, R., Wells, G. A., Sapp, J. L., Healey, J. S., Tardif, J.-C., Greiss, I., Rivard, L., Roux, J.-F., Gula, L., Nault, I., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.026230 · Cited by 101
Associations of Abdominal Obesity and New‐Onset Atrial Fibrillation in the General Population
Baek, Y., Yang, P., Kim, T., Uhm, J., Park, J., Pak, H., Lee, M., & Joung, B. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004705 · Cited by 100
Nielsen, J. C., Lin, Y., Figueiredo, M. J. D. O., Shamloo, A. S., Alfie, A., Bovéda, S., Dagres, N., Toro, D. D., Eckhardt, L. L., Ellenbogen, K. A., et al. (2020) · Journal of Arrhythmia · doi:10.1002/joa3.12338 · Cited by 106
Atrial fibrillation: comorbidities, lifestyle, and patient factors
Shantsila, E., Choi, E., Lane, D. A., Joung, B., & Lip, G. Y. H. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2023.100784 · Cited by 108
“82,129”
Atrial Fibrillation and Obesity
Mahajan, R., Lau, D. H., Brooks, A. G., SHIPP, N. J., Wood, J. P. M., Manavis, J., Samuel, C. S., Patel, K. P., Finnie, J. W., Alasady, M., et al. (2021) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2020.11.015 · Cited by 99
Self-citationCalkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-017-0277-z · Cited by 100
Self-citationChao, T., Joung, B., Takahashi, Y., Lim, T. W., Choi, E., Chan, Y., Guo, Y., Sriratanasathavorn, C., Oh, S., Okumura, K., et al. (2021) · Journal of Arrhythmia · doi:10.1002/joa3.12652 · Cited by 105
Quality indicators for the care and outcomes of adults with atrial fibrillation
Arbelo, E., (Chair), Aktaa, S., Bollmann, A., d’Ávila, A., Drossart, I., Dwight, J., Hills, M. T., Hindricks, G., Kusumoto, F. M., et al. (2020) · EP Europace · doi:10.1093/europace/euaa253 · Cited by 100
Self-citationSupervised Obesity Reduction Trial for AF ablation patients: results from the SORT-AF trial
Geßler, N., Willems, S., Steven, D., Aberle, J., Akbulak, R. Ö., Gosau, N., Hoffmann, B. A., Meyer, C. G., Sultan, A., Tilz, R. R., et al. (2021) · EP Europace · doi:10.1093/europace/euab122 · Cited by 98
“Follow-up was performed every 3–6 months by clinic review and 7-day Holter monitoring showing that aggressive RFM improved the long-term success of AF ablation.(8) Donnellan et al.”
MethodNielsen, J. C., Lin, Y.-J., de Oliveira Figueiredo, M. J., Sepehri Shamloo, A., Alfie, A., Boveda, S., Dagres, N., Di Toro, D., Eckhardt, L. L., Ellenbogen, K., et al. (2020) · EP Europace · doi:10.1093/europace/euaa065 · Cited by 98
Zhu, W., Wan, R., Liu, F., Hu, J., Huang, L., Li, J., & Hong, K. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004006 · Cited by 97
“In the Aggressive Risk Factor Reduction Study for Atrial Fibrillation and Implications for the Outcome of Ablation (ARREST-AF), aggressive risk factor modifications (ie, weight management) improved the long-term success of AF ablation.(72) Abed et al(19) indicated that weight reduction with intensive risk factor modif…”
BackgroundThe Interplay between Obstructive Sleep Apnea and Atrial Fibrillation
Marulanda-Londoño, E. T., & Chaturvedi, S. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00668 · Cited by 99
New Findings in Atrial Fibrillation Mechanisms
Lau, D. H., Linz, D., & Sanders, P. (2019) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2019.08.007 · Cited by 93
Self-citationInciardi, R. M., Bonelli, A., Biering‐Sørensen, T., Cameli, M., Pagnesi, M., Lombardi, C., Solomon, S. D., & Metra, M. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2562 · Cited by 95
Metabolic remodelling in atrial fibrillation: manifestations, mechanisms and clinical implications
Bode, D., Pronto, J. R. D., Schiattarella, G. G., & Voigt, N. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01038-6 · Cited by 98
Providencia, R. A., Lambiase, P. D., Srinivasan, N. T., Babu, G. G., Bronis, K., Ahsan, S., Khan, F. Z., CHOW, A. W. C., Rowland, E., LOWE, M. D., et al. (2015) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.115.003019 · Cited by 93
Voskoboinik, A., Wong, G. R., Lee, G., Nalliah, C. J., Hawson, J. J., Prabhu, S., Sugumar, H., Ling, L., McLellan, A. J. A., Morton, J. B., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2018.10.041 · Cited by 93
Self-citationDzeshka, M. S., Shahid, F., Shantsila, A., & Lip, G. Y. H. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpx013 · Cited by 91
Wijesurendra, R. S., Liu, A., Eichhorn, C., Ariga, R., Levelt, E., Clarke, W. T., Rodgers, C. T., Karamitsos, T. D., Bashir, Y., Ginks, M., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.022931 · Cited by 87
“48 We also show that the improvement in LVEF after ablation may not reflect beneficial LV remodeling induced by SR.”
Epidemiology of Atrial Fibrillation: The Australian and Asia-Pacific Perspective
Wong, C. X. J., Brown, A. D. H., Tse, H., Albert, C. M., Kalman, J. M., Marwick, T. H., Lau, D. H., & Sanders, P. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2017.05.120 · Cited by 89
Self-citationWorld Heart Federation Roadmap on Atrial Fibrillation – A 2020 Update
Freedman, B., Hindricks, G., Banerjee, A., Baranchuk, A. M., Ching, C. K., Du, X., Fitzsimons, D., Healey, J. S., Ikeda, T., Lobban, T., et al. (2021) · Global Heart · doi:10.5334/gh.1023 · Cited by 95
Anselmino, M., Matta, M., D'ascenzo, F., Pappone, C., Santinelli, V., Bunch, T. J., Neumann, T., Schilling, R. J., Hunter, R. J., Noelker, G., et al. (2015) · Europace · doi:10.1093/europace/euv214 · Cited by 88
“Optimal glyco-metabolic control and weight reduction may, therefore, be crucial to optimize AF management(36) – 38 and enhance ablation outcomes.(39) In fact, a one point increase in basal glycated haemoglobin raised by 0.”
BackgroundSelf-citationPathak, R. K., Evans, M., Middeldorp, M. E., Mahajan, R., Mehta, A. B., Meredith, M., Twomey, D. J., Wong, C. X. J., Hendriks, J., Abhayaratna, W. P., et al. (2017) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2016.12.015 · Cited by 87
Self-citationRamkumar, S., Nerlekar, N., D’Souza, D., Pol, D. J., Kalman, J. M., & Marwick, T. H. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-024178 · Cited by 91
“Aggressive lifestyle intervention in patients with AF undergoing catheter ablation has been reported to lead to a reduction in symptom burden, improved quality of life and the need for repeat ablation procedures.(10) It remains to be tested whether initiation of Table 4 Outlier studies omitted (24 hours Holter) to ass…”
BackgroundSelf-citationDonnellan, E., Wazni, O. M., Kanj, M. H., Baranowski, B. J., Cremer, P. C., Harb, S. C., McCarthy, C. P., McEvoy, J. W., Elshazly, M. B., Aagaard, P., et al. (2019) · EP Europace · doi:10.1093/europace/euz183 · Cited by 91
Atrial Fibrillation and Endothelial Dysfunction
Corban, M., Toya, T., Ahmad, A., Lerman, L. O., Lee, H.-C., & Lerman, A. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.11.005 · Cited by 87
Tang, S., Razeghi, O., Kapoor, R., Alhusseini, M. I., Fazal, M., Rogers, A. J., Rodrigo, M., Clopton, P., Wang, P. J., Rubin, D. L., et al. (2022) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.122.010850 · Cited by 89
New-onset atrial fibrillation prediction: the HARMS2-AF risk score
Segan, L. A., Cánovas, R., Nanayakkara, S., Chieng, D., Prabhu, S., Voskoboinik, A., Sugumar, H., Ling, L., Lee, G., Morton, J. B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad375 · Cited by 90
Self-citationSympathetic Nervous System Activation and Its Modulation: Role in Atrial Fibrillation
Carnagarin, R., Kiuchi, M. G., Ho, J. K., Matthews, V. B., & Schlaich, M. P. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.01058 · Cited by 81
Providencia, R. A., Adragão, P., de Asmundis, C., Chun, K. R. J., Chierchia, G., Defaye, P., Anselme, F., Creta, A., Lambiase, P. D., Schmidt, B., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012253 · Cited by 79
van den Dries, C. J., van Doorn, S., Rutten, F. H., Oudega, R., van de Leur, S. J. C. M., Elvan, A., Grave, L. O., Bilo, H. J. G., Moons, K. G. M., Hoes, A. W., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa055 · Cited by 79
Donnellan, E., Wazni, O. M., Kanj, M. H., Hussein, A. A., Baranowski, B. J., Lindsay, B. D., Aminian, A., Jaber, W. A., Schauer, P. R., & Saliba, W. I. (2019) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.119.007598 · Cited by 79
Erhard, N., Metzner, A., & Fink, T. (2022) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-021-00836-6 · Cited by 79
“daemia, hypertension or obstructive sleep apnoea (OSA) [26, 39, 43].”
BackgroundInfluentialGuía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Bénétos, A., Biffi, A., Boavida, J. M., Capodanno, D., et al. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.10.016 · Cited by 89
Gaïta, F., Scaglione, M., Battaglia, A., Matta, M., Gallo, C., Galatà, M., Caponi, D., Donna, P. D., & Anselmino, M. (2017) · EP Europace · doi:10.1093/europace/eux008 · Cited by 78
Impact of CPAP on the Atrial Fibrillation Substrate in Obstructive Sleep Apnea
Nalliah, C. J., Wong, G. R., Lee, G., Voskoboinik, A., Kee, K., Goldin, J., Watts, T. W., Linz, D., Parameswaran, R., Sugumar, H., et al. (2022) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2022.04.015 · Cited by 76
Self-citationChen, K., Bai, R., Deng, W., Gao, C., Zhang, J., Wang, X., Wang, S., Fu, H., Zhao, Y., Zhang, J., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.04.008 · Cited by 75
Atrial arrhythmogenesis in obstructive sleep apnea: Therapeutic implications
Linz, D., Linz, B. M., Hohl, M., & Böhm, M. (2015) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2015.03.003 · Cited by 76
Oxidant and Inflammatory Mechanisms and Targeted Therapy in Atrial Fibrillation
Gutiérrez, A., & Wagoner, D. R. V. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000313 · Cited by 74
“These interventions were also associated with improved outcomes after interventional procedures.(35) As noted by Hippocrates, food is medicine.”
Pulmonary Vein Antrum Isolation in Patients With Paroxysmal Atrial Fibrillation
Gökoğlan, Y., Mohanty, S., Günes, M. F., Trivedi, C. G., Santangeli, P., Gianni, C., Asfour, I., Bai, R., Burkhardt, J. D., Horton, R., et al. (2016) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.115.003660 · Cited by 73
“In this context, it is worth mentioning that the Aggressive Risk Factor Reduction Study-Implication for AF (ARREST-AF) study has reported improved long-term success of AF ablation in a majorly PAF population from a single center after aggressive risk factor reduction and efficient weight management.(47) However, this…”
BackgroundTzeis, S. E., Gerstenfeld, E. P., Kalman, J. M., Saad, E., Shamloo, A. S., Andrade, J. G., Barbhaiya, C. R., Baykaner, T., Bovéda, S., Calkins, H. G., et al. (2024) · Journal of Arrhythmia · doi:10.1002/joa3.13082 · Cited by 76
Self-citationHöskuldsdóttir, G., Sattar, N., Miftaraj, M., Näslund, I., Ottosson, J., Franzén, S., Svensson, A., & Eliasson, B. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019323 · Cited by 70
“29 It is therefore likely that the weight loss and positive effects on glycemic control after surgery are particularly important with regard to the risk reduction observed in this patient group.”
Atrial fibrillation and gastroesophageal reflux disease: the cardiogastric interaction
Linz, D., Hohl, M., Vollmar, J., Ukena, C., Mahfoud, F., & Böhm, M. (2016) · EP Europace · doi:10.1093/europace/euw092 · Cited by 72
“factor management according to American Heart Association/ American College of Cardiology guidelines improved the long-term success of AF ablation.(46,47)”
MethodMcCabe, P. J., Stuart-Mullen, L. G., McLeod, C. J., Byrne, T. O., Schmidt, M. M., Branda, M. E., & Griffin, J. M. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s172970 · Cited by 73
Epicardial adipose tissue as a mediator of cardiac arrhythmias
Patel, K. H. K., Hwang, T., Liebers, C. S., & Ng, F. S. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00565.2021 · Cited by 77
Fabritz, L., Crijns, H. J. G. M., Guasch, E., Goette, A., Häusler, K. G., Kotecha, D., Lewalter, T., Meyer, C. G., Potpara, T., Rienstra, M., et al. (2020) · EP Europace · doi:10.1093/europace/euaa279 · Cited by 70
Mahdiui, M. E., Simon, J., Smit, J. M., Kuneman, J. H., van Rosendael, A. R., Steyerberg, E. W., van der Geest, R. J., Száraz, L., Herczeg, S., Szegedi, N., et al. (2021) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.120.009135 · Cited by 68
Challenges in Cardiovascular Evaluation and Management of Obese Patients
Bianchettin, R. G., Lavie, C. J., & López-Jiménez, F. A. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.11.031 · Cited by 73
Thrombus Formation After Left Atrial Appendage Occlusion With the Amplatzer Amulet Device
Sedaghat, A., Schrickel, J. W., Andrié, R., Schueler, R., Nickenig, G., & Hammerstingl, C. (2016) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2016.05.006 · Cited by 68
Stroke risk in women with atrial fibrillation
Buhari, H., Fang, J., Han, L., Austin, P. C., Dorian, P., Jackevicius, C. A., Yu, A., Kapral, M. K., Singh, S. M., Tu, K., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad508 · Cited by 64
Mohanty, S., Mohanty, P. K., Natale, V. N., Trivedi, C. G., Gianni, C., Burkhardt, J. D., Sánchez, J., Horton, R., Gallinghouse, G. J., Hongo, R. H., et al. (2017) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13394 · Cited by 66
“5 But, this finding cannot be generalized to global AF population for several reasons: (1) nonrandomized study design; (2) inclusion of paroxysmal and persistent AF only; (3) plausible underestimation of recurrent events due to a not-so-rigorous follow-up regimen; arrhythmia monitoring at yearly interval might have mi…”
BackgroundMekhael, M., Marrouche, N. F., Hajjar, A. H. E., & Donnellan, E. (2022) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2022.09.006 · Cited by 67
Vagal atrial fibrillation: What is it and should we treat it?
Carpenter, A., Frontera, A., Bond, R., Duncan, E., & Thomas, G. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.08.108 · Cited by 65
Kato, M., Ogano, M., Mori, Y., Kochi, K., Morimoto, D., Kito, K., Nihei, F., Tsukamoto, T., Akira, K. U. B. O., Takagi, H., et al. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319859974 · Cited by 67
“demonstrated that aggressive risk factor management improved the long-term success of atrial fibrillation ablation.(28) Therefore, a longer follow-up might have reinforced the value of the study.”
BackgroundTzeis, S. E., Gerstenfeld, E. P., Kalman, J. M., Saad, E., Shamloo, A. S., Andrade, J. G., Barbhaiya, C. R., Baykaner, T., Bovéda, S., Calkins, H. G., et al. (2024) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-024-01771-5 · Cited by 66
Self-citationSkielboe, A. K., Bandholm, T., Hakmann, S., Mourier, M., Kallemose, T., & Dixen, U. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170060 · Cited by 69
Creta, A., Providencia, R. A., Adragão, P., de Asmundis, C., Chun, K. R. J., Chierchia, G., Defaye, P., Schmidt, B., Anselme, F., Finlay, M., et al. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.12.037 · Cited by 66
Obesity and atrial fibrillation: making inroads through fat
Javed, S., Gupta, D., & Lip, G. Y. H. (2020) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvaa013 · Cited by 65
Elliott, A. D., Maatman, B. T., Emery, M. S., & Sanders, P. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.07.001 · Cited by 63
Self-citationSato, T., Aizawa, Y., Yuasa, S., Fujita, S., Ikeda, Y., & Okabe, M. (2020) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.48009 · Cited by 63
Atrial Myopathy Underlying Atrial Fibrillation
Rivner, H., Mitrani, R. D., & Goldberger, J. J. (2020) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2020.13 · Cited by 64
“While the mechanism is unclear, improvements in atrial volume on echocardiography suggest that it may be due to reversal of the underlying cardiomyopathy.(165) As a result, the latest ACC/AHA guidelines for AF recommend weight loss in obese patients with a Class I indication.”
BackgroundObesity and cardiovascular risk
Kotsis, V., Tsioufis, K. P., Antza, C., Seravalle, G., Coca, A., Sierra, C., Lurbe, E., Stabouli, S., Jelaković, B., Redón, J., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001731 · Cited by 66
Atrial Fibrillation in Active Cancer Patients: Expert Position Paper and Recommendations
López‐Fernández, T., Martín‐Garcia, A., Rabadán, I. R., Mitroi, C. D., Mazón‐Ramos, P., Díez‐Villanueva, P., Escobar, C., Alonso‐Martín, C., Salinas, G. L. A., Arenas, M., et al. (2019) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2019.03.019 · Cited by 62
Piccini, J. P., Allred, J. D., Bunch, T. J., Deering, T. F., Biase, L. D., Hussein, A. A., Lewis, W. R., Mittal, S., Natale, A., Osorio, J., et al. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.04.033 · Cited by 63
“Prescribing OAC to reduce the risk of stroke and systemic embolism, while minimizing the risk of bleeding, is a critical component in the treatment of patients with AF and a core competency for any AF CoE.”
BackgroundInfluentialSelf-citationAblation of Atrial Fibrillation
Link, M. S., Haı̈ssaguerre, M., & Natale, A. (2016) · Circulation · doi:10.1161/circulationaha.116.021727 · Cited by 64
Charitakis, E., Barmano, N., Walfridsson, U., & Walfridsson, H. (2017) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2016.12.004 · Cited by 61
“(39) showed that aggressive risk factor modification improved the long-term success of AF ablation, and that cardiorespiratory fitness predicted arrhythmia recurrence in obese patients with symptomatic AF (40).”
BackgroundHoman, E. A., Reyes, M. V., Hickey, K. T., & Morrow, J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01847 · Cited by 63
Impact of Bariatric Surgery on Atrial Fibrillation Type
Donnellan, E., Wazni, O. M., Elshazly, M. B., Kanj, M. H., Hussein, A. A., Baranowski, B. J., Kochar, A., Trulock, K. M., Aminian, A., Schauer, P. R., et al. (2020) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.119.007626 · Cited by 62
Lifestyle Modification in the Prevention and Treatment of Atrial Fibrillation
Menezes, A. R., Lavie, C. J., Schutter, A. D., Milani, R. V., O’Keefe, J. H., DiNicolantonio, J. J., Morin, D. P., & ABI‐SAMRA, F. M. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.07.001 · Cited by 58
“Finally, among overweight patients, risk factor management (RFM), as per the guidelines set by the American Heart Association and the American College of Cardiology, has been associated with improved long-term success of AF ablation.(36) In this study, individuals with a BMI ≥27 kg/m(2) and ≥1 CHD risk factor were off…”
BackgroundThe why, when and how to test for obstructive sleep apnea in patients with atrial fibrillation
Desteghe, L., Hendriks, J., McEvoy, R. D., Chai‐Coetzer, C. L., Dendale, P., Sanders, P., Heidbüchel, H., & Linz, D. (2018) · Clinical Research in Cardiology · doi:10.1007/s00392-018-1248-9 · Cited by 59
Self-citationHendriks, J., Tieleman, R. G., Vrijhoef, H. J., Wijtvliet, P., Gallagher, C., Prins, M. H., Sanders, P., & Crijns, H. J. G. M. (2019) · EP Europace · doi:10.1093/europace/euz209 · Cited by 58
Self-citationDual-Channel Neural Network for Atrial Fibrillation Detection From a Single Lead ECG Wave
Fang, B., Chen, J., Liu, Y., Wang, W. W., Wang, K., Singh, A. K., & Lv, Z. (2021) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2021.3120890 · Cited by 57
Metadata
- Authors
- Pathak, R. K., Middeldorp, M. E., Lau, D. H., Mehta, A. B., Mahajan, R., Twomey, D., Alasady, M., Hanley, L., Antic, N. A., McEvoy, R. D., Kalman, J. M., Abhayaratna, W. P., & Sanders, P.
- Affiliations
- Royal Adelaide Hospital (AU)
- Australian National University (AU)
- Flinders University (AU)
- The Royal Melbourne Hospital (AU)
- Corresponding author
- Sanders, Prashanthan
- ORCID
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2014-12
- Volume
- 64
- Issue
- 21
- Pages
- 2222-2231
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W140098974
- Semantic Scholar
- f4c9c27c3ab3730d2c2ca09e8648704e91ba7fde
- Cited by
- 949
- References
- 44
- Citations by year
- 2026: 57 · 2025: 85 · 2024: 72 · 2023: 73 · 2022: 81 · 2021: 107 · 2020: 97 · 2019: 80 · 2018: 70 · 2017: 92 · 2016: 79 · 2015: 52 · 2014: 4
- FWCI
- 52.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Flinders Academic Commons (Flinders University) (publishedVersion)
- ANU Open Research (Australian National University) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Flinders Academic Commons (Flinders University) (submittedVersion)
- Funders
- ResMed
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- atrial fibrillation, catheter ablation, cardiovascular risk management, obesity, weight loss, blood pressure reduction, glycemic control, lipid profile, arrhythmia-free survival, atrial fibrillation substrate, antiarrhythmic drugs, atrial fibrillation recurrence
- MeSH terms
- Alcohol Drinking, Atrial Fibrillation, Blood Glucose, Blood Pressure, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Life Style, Lipids, Male, Middle Aged, Recurrence, Risk Factors, Severity of Illness Index, Cohort Studies, Body Mass Index, Case-Control Studies, Smoking Cessation, Catheter Ablation, Sleep Apnea, Obstructive, Dyslipidemias, Weight Reduction Programs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
